Risk stratification of patients listed for heart transplantation while supported with extracorporeal membrane oxygenation.
heart transplant extra-corporeal membrane oxygenation
prognosis
Journal
The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
15
01
2021
revised:
03
05
2021
accepted:
17
05
2021
pubmed:
26
6
2021
medline:
17
1
2023
entrez:
25
6
2021
Statut:
ppublish
Résumé
Extracorporeal membrane oxygenation (ECMO) is used to support patients in severe cardiogenic shock. In the absence of recovery, these patients may need to be listed for heart transplant (HT), which offers the best long-term prognosis. However, posttransplantation mortality is significantly elevated in patients who receive ECMO. The objective of the present study was to describe and risk-stratify different profiles of patients listed for HT supported by ECMO. Patients listed for HT in the United Network for Organ Sharing database were analyzed. The primary outcome was 1-year survival and was assessed in patients bridged to transplant with ECMO (ECMO Among 65,636 adult candidates listed for HT (between 2001 and 2017), 712 were supported on ECMO, 292 of whom (41%) underwent HT (ECMO The HT recipients in the ECMO
Identifiants
pubmed: 34167814
pii: S0022-5223(21)00877-1
doi: 10.1016/j.jtcvs.2021.05.032
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
711-720Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2021 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.